Vaginal tamoxifen – A potential treatment option for vaginal atrophysymptoms in postmenopausal women who cannot use estrogen
33:22
Mastologia
Tamoxifen vaginal funciona? Uma Prova de Conceito e Da teoria à prática: GLP-1 R. Agonista em câncer de mama
Podcast
26/03/2026
05:00
Português
Weight Loss Patterns and Clinical Outcomes ofGLP1 Receptor Agonists in Breast Cancer Survivors
Obesity and Cancer A Translational Science Review
CancerVIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER22/ PIK3CA Wild-Type Advanced Breast Cancer
Is Lobular Histology a Predictor of Sentinel Node Positivity in Early Breast Cancer? An Integrated Analysis of Histological Subtype and Preoperative Imaging
38:47
Mastologia
Podemos omitir a abordagem axilar para CA Lobular Invasivo Luminal A inicial? / VIKTORIA-1 trial: aumento do PFS com novo bloqueio PI3K/mTOR em CA Avançado
Podcast
19/03/2026
05:00
Português
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With orWithout Palbociclib in Hormone Receptor–Positive/HER22/PIK3CA Wild-Type Advanced Breast Cancer
38:47
Mastologia
Teste genético sem critérios / Análise combinada dos estudos DESTINY‑Breast 01/02/03 no câncer de mama metastático HER2+
Podcast
12/03/2026
05:00
Português
Diagnostic accuracy of FDG-PET-CT to predictaxillary lymph node response after neoadjuvant chemotherapy in lymph nodepositive breast cancer patients
Extended Endocrine Therapy Following 5 Years of AdjuvantLuteinizing Hormone-Releasing Hormone Agonist inPremenopausal Patients With Node-Positive, HormoneReceptor–Positive Breast Cancer: A Cohort Study
Germline Pathogenic Variants AmongWomenWithout a History of Breast Cancer A Secondary Analysis of the WISDOM Randomized Clinical Trial





